Discover how CRISPR gene editing is transforming treatment for primary hyperoxaluria type 1, offering a potential one-time cure for this rare genetic kidney disease.
Exploring how gene therapy and CRISPR technology are transforming treatment for rare metabolic disorders through breakthrough cases like CPS1 deficiency.